5-amino-1mq and cd38 inhibitor synergy nad+

5-amino-1mq and cd38 inhibitor synergy nad+ Frontiers SLC25A51 decouples the mitochondrial NAD+/NADH

Name: 5-amino-1mq and cd38 inhibitor synergy nad+ Frontiers SLC25A51 decouples the mitochondrial NAD+/NADH
Brand: www.marsberger-treibhaus.de
SKU: 45065208444
Price: 28.38 USD
Availability: InStock
Rating: 4.5337000000000005 (12 reviews)

SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism Inhibition of CD38 by 78c Enhanced NAD+, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens Discovery of a First in Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy Journal of Medicinal Chemistry Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers

SKU: 45065208444 · From www.marsberger-treibhaus.de

4.5

USD28.38 USD75.38

Pay in 4 interest-free payments of $7.09 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

Johnson TE et al

Skipping doses can interrupt the gradual metabolic improvements

A 2008 study published in the Journal of Medicinal Chemistry demonstrated metabolic effects in rodent models at 50mg/kg, which led early researchers to extrapolate human-equivalent doses between 50100mg daily